Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign

By Oli Hudson

- PMLiVE

Healing the Healers

Because if we do not heal the healers, who is going to heal us?

Havas Lynx

The (inevitable) digital transformation of Medical Affairs

It’s not a question of ‘if,’ it’s a question of ‘when.’

Impetus Digital

- PMLiVE

Novartis receives EC approval for Cosentyx in hidradenitis suppurativa

There are around 200,000 people in Europe living with moderate to severe stages of HS

- PMLiVE

Pfizer’s RSV vaccine approved by FDA for older adults

RSV infections in older adults account for up to 160,000 hospitalisations each year in the US

- PMLiVE

Engaging with patients will create more effective patient pathways

By Su Smith

- PMLiVE

Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer

Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.

Avalere Health

- PMLiVE

Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment

Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...

Avalere Health

- PMLiVE

Sanofi’s frexalimab shows promise in relapsing forms of MS

The neurological disease affects approximately 2.8 million people worldwide

- PMLiVE

Listening to patients when they have something to say, not just when we want an answer

By Harry Yeates

- PMLiVE

Amgen reports positive results for inflammatory disease drug Otezla in psoriatic arthritis

The inflammatory condition is estimated to affect nearly 38 million people worldwide

- PMLiVE

UK life sciences sector to receive £650m in government funding

The package includes £121m to speed up clinical trials and improve access to data

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links